AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors. Barchart 13h
Business Watch: Evonik to cut 3,200 jobs; AbbVie buys Apogee for almost $11 billion Chemical & Engineering News 14h
AbbVie Inc. (ABBV) is a trending stock: Facts to know before betting on it Zacks 7d AbbVie Inc Pharma
Offworld space biology: Setting up the Life Science glovebox Astrobiology Web 16h International Space Station Science Biotechnology
Pfizer's Seagen-derived ADC pipeline suffers a setback pharmaphorum 1d Lung Cancer Pfizer Tidal Power
STAT Plus: Gene-editing startup launches with $230 million and a Chinese licensing deal STAT 21h CRISPR/Gene Editing Biotechnology Pharma
STAT Plus: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program STAT 19h Biotechnology Pharma Healthcare
Sparkling Sciences Obtains International Inci Certification for iPSC Exosome PR Newswire (Press Release) 20h Biotechnology
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI Aayog The Times of India 21h Pharma India China
